Pain medicine

Bilateral ultrasound-guided maxillary and mandibular combined nerves block reduces morphine consumption after double-jaw orthognathic surgery: a randomized controlled trial

Reg Anesth Pain MedPublished Randomised controlled trial

Primary result · Cumulative OME consumptionResult — go to the resultMean difference −20.1 mg 95% CI −37.4 to −2.9

Authors' conclusion

Bilateral ultrasound-guided V2 and V3 combined nerves block reduces postoperative opioid consumption by about 50% in patients undergoing double-jaw surgery.

Study context

Population
Patients undergoing double-jaw orthognathic surgery
Participants
50 patients
Comparison
V2 and V3 block vs Infiltration
Primary endpoint
Cumulative oral morphine equivalent (OME) consumption
Follow-up
POD 1
Methodological detailssingle-blind, prospective
  • Single-blind
  • Prospective

Primary result

Cumulative OME consumption · Day 1

Mean difference

−20.1 mg

95% CI −37.4 to −2.9

P = 0.023

By group

V2 and V3 block vs Infiltration
mean difference −20.1 mg (95% CI −37.4 to −2.9); P = 0.023

As reported in the abstract

Secondary outcomes

Mean, mg

OutcomeV2 and V3 blockInfiltrationMean difference (mg) (95% CI)P value
Cumulative OME consumption · Day 235.8 (SD 30.2)64.5 (SD 60)−28.7 (−55.9 to −1.43)P = 0.040

Correlation of preoperative anxiety (Amsterdam Preoperative Anxiety and Information Scale (APAIS)) with worst pain score and cumulative oral morphine equivalent (OME) consumption on day 2

Worst pain score vs APAIS, Pearson's correlation coefficient (p=0.003)
0.42
Cumulative OME consumption vs APAIS, Pearson's correlation coefficient (p=0.006)
0.39

Original publication

Bilateral ultrasound-guided maxillary and mandibular combined nerves block reduces morphine consumption after double-jaw orthognathic surgery: a randomized controlled trial. Reg Anesth Pain Med. Published 2 May 2024. doi:10.1136/rapm-2024-105497

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.